Pregled bibliografske jedinice broj: 880080
The burden of rare genetic variants in genes involved in tumor necrosis factor (TNF) signalling pathway in multiple sclerosis (MS).
The burden of rare genetic variants in genes involved in tumor necrosis factor (TNF) signalling pathway in multiple sclerosis (MS). // European Journal of Human Genetics
Kopenhagen, Danska, 2017. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 880080 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The burden of rare genetic variants in genes involved in tumor necrosis factor (TNF) signalling pathway in multiple sclerosis (MS).
Autori
Peterin, Ana ; Maver, Aleš ; Hodžić, Alenka ; Šega, Saša ; Drulović, Jelena ; Novaković, Ivana ; Pekmezović, Tatjana ; Ristić, Smiljana ; Kapović, Miljenko, Peterlin, Borut.
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
European Journal of Human Genetics
/ - , 2017
Skup
European Human Genetics Conference
Mjesto i datum
Kopenhagen, Danska, 27.05.2017. - 30.05.2017
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
Multiple Sclerosis, TNF pathway, Burden
Sažetak
Introduction: MS is a chronic inflammatory disease of central nervous system with widely studied, however still poorly understood genetic contribution. Several lines of evidence imply an important role of TNF pathway in the pathogenesis of MS including inflammatory demyelination of central nervous system observed in TNF receptor-associated periodic syndrome (TRAPS) caused by rare mutations in TNFRSF1A. Therefore, we hypothesized that an increased mutation burden in genes involved in TNF signalling pathway may trigger inflammation in MS.Materials and Methods: Nextera Coding Exome enrichment was used to perform Whole exome sequencing of 35 patients with familial MS, 43 patients with sporadic MS and 91 population matched controls. Genotypes were called using GATK toolkit. The selection of variants among 110 genes involved in TNF signalling pathway (KEGG database) was narrowed down by evaluation of functional impact of in silico predictors: Meta-SVM (when described as damaging) and/or CADD (when N > 20). Results: We identified 56 rare potentially pathogenic genetic variants in 37 genes. We detected a statistically significant increased burden of rare genetic variants in sporadic (x2=5.42, p=0.02), but not in the familial cases of MS (x2=0.13, p=0.72), when compared to controls. Conclusions: We found evidence for an increased burden of rare genetic variants in genes of the TNF signalling pathway in sporadic MS patients, which further supports its pathogenetic role in MS.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Scopus
- MEDLINE